DermTech Valuation
| DMTK Stock | USD 0.59 0.02 3.28% |
DermTech is undervalued. DermTech shows a prevailing Real Value of $1.71 per share. The current price of the firm is $0.59. Our model computes the value of DermTech from reviewing the firm fundamentals such as Operating Margin of (5.03) %, shares owned by insiders of 4.24 %, and Shares Outstanding of 34.62 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise picking up undervalued instruments and discarding overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting DermTech's valuation include:
Price Book 0.3803 | Enterprise Value 19.8 M | Enterprise Value Ebitda (0.21) | Price Sales 1.4079 | Enterprise Value Revenue 1.3254 |
Undervalued
Today
Please note that DermTech's price fluctuation is dangerous at this time. Calculation of the real value of DermTech is based on 3 months time horizon. Increasing DermTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for DermTech is useful when determining the fair value of the DermTech stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of DermTech. Since DermTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DermTech Stock. However, DermTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.59 | Real 1.71 | Target 5.1 | Hype 0.55 | Naive 0.47 |
The real value of DermTech Stock, also known as its intrinsic value, is the underlying worth of DermTech Company, which is reflected in its stock price. It is based on DermTech's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of DermTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DermTech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DermTech helps investors to forecast how DermTech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DermTech more accurately as focusing exclusively on DermTech's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use DermTech's intrinsic value based on its ongoing forecasts of DermTech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against DermTech's closest peers. When choosing an evaluation method for DermTech, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
DermTech Investments |
|
DermTech Valuation Trend
Knowing DermTech's actual value is paramount for traders to make sound investment determinations. DermTech's real value is not only important for the investor to make better decisions but also for a more accurate overall view of DermTech's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both DermTech's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
DermTech Market Cap
DermTech is rated # 3 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 438.65 Million. DermTech holds roughly 21.26 Million in market capitalization claiming about 5% of equities under Health Care industry.DermTech Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining DermTech's current stock value. Our valuation model uses many indicators to compare DermTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DermTech competition to find correlations between indicators driving DermTech's intrinsic value. More Info.DermTech is one of the top stocks in price to earning category among related companies. It is rated # 2 in price to book category among related companies . The value of Price To Book Ratio is estimated to slide to 0.95. Comparative valuation analysis is a catch-all model that can be used if you cannot value DermTech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DermTech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DermTech's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DermTech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DermTech and how it compares across the competition.
About DermTech Valuation
The stock valuation mechanism determines the current worth of DermTech on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of DermTech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of DermTech based exclusively on its fundamental and basic technical indicators. By analyzing DermTech's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of DermTech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of DermTech. We calculate exposure to DermTech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DermTech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 276 K | 289.8 K | |
| Pretax Profit Margin | (6.60) | (6.93) | |
| Operating Profit Margin | (6.78) | (7.12) | |
| Net Loss | (6.60) | (6.93) | |
| Gross Profit Margin | 0.02 | 0.03 |
8 Steps to conduct DermTech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DermTech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DermTech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DermTech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DermTech's revenue streams: Identify DermTech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DermTech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DermTech's growth potential: Evaluate DermTech's management, business model, and growth potential.
- Determine DermTech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DermTech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
DermTech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as DermTech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 32.6 M |
DermTech Current Valuation Indicators
Valuation refers to the process of determining the present value of DermTech and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value DermTech we look at many different elements of the entity such as DermTech's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. DermTech's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final DermTech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as DermTech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use DermTech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes DermTech's worth.When determining whether DermTech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DermTech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dermtech Stock. Highlighted below are key reports to facilitate an investment decision about Dermtech Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.